Literature DB >> 3515220

Renal transplantation in diabetes mellitus. Influence of preexisting vascular disease on outcome.

J M Rimmer, M Sussman, R Foster, F J Gennari.   

Abstract

We reviewed the recommendations and outcomes for all patients with diabetes mellitus and end-stage renal disease referred to the Medical Center Hospital of Vermont from 1971 through December 1983. During this period, we recommended transplantation in 53 of 73 patients evaluated. Thirty-two transplants were performed in 30 patients. Of the 30 patients, 10 had clinical vascular disease prior to transplantation, i.e., claudication, amputation, active angina, myocardial infarction, or stroke. Seven of the 10 had only claudication or amputation. These 10 patients showed a clear excess in graft failure and mortality. One- and 2-year graft survival was 37 and 13%; patient survival was 48 and 24%. By comparison, the 20 patients without evident vascular disease had 1- and 2-year graft survival rates of 83 and 75% and patient survival rates of 85% at both 1 and 2 years. The incidence of cardiovascular death in the group with vascular disease was 45% at 1 year and 63% at 2 years, as compared with none in the group without vascular disease. The high graft loss and mortality in this group after transplantation should be a major consideration when therapeutic alternatives are considered in diabetics with end-stage renal disease.

Entities:  

Mesh:

Year:  1986        PMID: 3515220     DOI: 10.1159/000183693

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  Long-term follow-up of renal transplantation in type 1 and type 2 diabetic patients.

Authors:  M M Hirschl; K Derfler; G Heinz; G Sunder-Plassmann; W Waldhäusl
Journal:  Clin Investig       Date:  1992-10

2.  Renal replacement treatment for diabetic nephropathy in Northern Ireland 1979-1987.

Authors:  A P Maxwell; J F Douglas; C C Doherty; W E Nelson; R A Donaldson; M G McGeown
Journal:  Ulster Med J       Date:  1988-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.